ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES

  • A.V. Demchuk Vinnytsia National Pirogov Memorial Medical University
Keywords: the community-acquired pneumonia, treatment, chronic comorbidities

Abstract

With purpose to assess the volume and rationality of prescription of medicines for the community-acquired pneumonia (CAP) treatment in patients with chronic comorbidities a prospective study of 438 in-patients (214 men (48.9%), average age - 56,1 ± 17,9) was conducted. Chronic comorbidities were in 359 (82.0%) patients. Controlled comorbidities were in 115 (26.3%), uncontrolled - 120 (27.4%), complicated chronic diseases - 124 (28.3%). Comorbidities were absent in 79 (18.0%) patients. There were significant polypharmacy of CAP patients, mean amount of medicines was 11,0 ± 4,0. Complicated chronic diseases in patients with CAP caused prescription of 13,7 ± 5,0 drugs. CAP in-patients with uncontrolled chronic diseases received 11,0 ± 2,9 medicines. CAP in-patients with controlled comorbidities used 9,7 ± 2,7 medicines and patients without comorbidity treated with 8,4 ± 2,5 drugs (p <0.001). All patients received antibiotics, as mandatory CAP treatment. Mucolytics were prescribed 92.7%, dextrans solutions - 36.0%, which was necessary due to features of CAP course. NSAIDs were administered 48.6% patients, but half of them did not need use these medications. Using sulfocamphocaine (39.0%), thiotriazoline (25.1%) and plasmol (13.2%) did not have any positive effect at the clinical course and outcome of CAP, it was mistaken.

Downloads

Download data is not yet available.

References

1. Blasi F, et al. Understanding the burden of pneumococcal disease in adults. Clinical Microbiology and Infection .2012; 18: 7-14.
2. Woodhead M, Guidelines for the management of adult lower respiratory tract infections – full version. Clin. Microbiol. Infect. 2011; 17(Suppl. 6): 1-59.
3. The protocol of care for patients with community acquired and nosocomial (hospital) pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibiotic therapy. On approving the protocols of care, specialty "Pulmonology": Ministry of Health of Ukraine №128. 19.03.2007. Kyiv, 2007, 146 p.
4. Gnjidic D, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012; 65: 989-995.
5. D’Aimmo MR, Modesto M, Biavati B. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int. J. Food. Microbiol. 2007; 115(1): 35-42.
6. Cremonini F, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhea. Aliment. Pharmacol. Ther. 2002; 16(8): 1461-1467.
7. D’Souza AL, et al. Probiotics in prevention of antibiotic associated diarrhea: meta-analysis. BMJ. 2002; 324(7350): 1361.
8. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol. 2006; 101(4): 812-822.
9. Lonnermark E, et al. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J. Clin. Gastroenterol. 2010; 44(2): 106-112.
10. Feschenko YI, et al. Pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibiotic therapy. Ed. YI Feschenko; SI "National Institute of tuberculosis and Pulmonology Institute. FG Yanovsky AMS of Ukraine. " - Kyiv, 2013. - 171 p.
11. Practical Guide to anti-infective chimiotherapy. Ed. LS Stratchounski, JB Belousov, SN Kozlov. Access: www.antibiotic.ru/ab/007-11shtml.
Ilyuk, I. A, Clinical efficacy of treatment of community acquired pneumonia with use thiotriazoline. Ukr. Pulmon. J. 2014; Number 4: 69-72.
Published
2017-03-21
How to Cite
Demchuk, A. (2017). ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES. The Medical and Ecological Problems, 19(3-4), 44-48. Retrieved from https://ecomed-journal.org/index.php/journal/article/view/51